INMB

INMUNE BIO INC

INMB·45782T105·US·Common Stock·Healthcare - Biotechnology-13D/G

INMB (INMUNE BIO INC) is held by 56 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($1.3M), VANGUARD CAPITAL MANAGEMENT LLC ($776,327), GEODE CAPITAL MANAGEMENT, LLC ($559,464). Net institutional sentiment: Mixed.

56
Holders
Avg rating(15 Elite)
$5.6M
Total Value
52% (62)
Fund Consensus
26 buying - 24 selling
INMBSmart Money Verdict
View all
Held by 56 funds
15 elite
Who's Trading
ActivistHIHighbridge Capital Management, LLC5.2%Aug 14, 2025
ActivistCICVI Investments, Inc.4.9%Aug 14, 2025
ActivistPPPraetorian PR LLC2.9%Aug 14, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
1.2M(-1.5%)$1.3M0.0%-58.56%
0
New
687,015$776,3270.0%+38.57%
38
Increased
494,969(+12.1%)$559,4640.0%-73.92%
19
Decreased
290,879(-16.2%)$328,6930.0%-70.67%
0
Increased
270,317(+1217.4%)$305,4580.0%+33.47%
38
Increased
253,340(+316.7%)$286,2740.0%-21.83%
26
Increased
231,586(+310.1%)$261,6920.0%+17.55%
25
Decreased
203,245(-3.5%)$229,6670.0%-58.28%
0
Decreased
194,391(-22.5%)$219,6620.0%-12.45%
0
Increased
184,225(+4.9%)$208,1740.0%-69.39%
16
New
129,218$146,0160.0%+38.57%
34
New
123,184$139,1980.0%+38.57%
34
Decreased
53,628(-8.4%)$60,5990.0%-74.40%
0
Increased
50,944(+121.9%)$57,5660.0%+12.80%
23
Unchanged
50,252$56,7850.0%-71.62%
0
Decreased
44,611(-63.6%)$50,4110.0%-52.29%
0
Increased
40,120(+6.1%)$45,3360.0%-61.58%
15
Decreased
33,245(-19.6%)$37,8990.0%-63.19%
0
Increased
32,362(+90.8%)$36,5690.0%+28.92%
31
Decreased
30,306(-56.0%)$34,2460.0%-53.68%
0

Showing 1-20 of 62

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used